- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07393971
Development of a Real-time Controller to Estimate Walking Performance Using a Bilateral Ankle Exoskeleton
June 1, 2026 updated by: University of Nebraska
Controller Development to Enable Individualized Assistance in Robotic Ankle Exoskeletons
This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people while they walk.
The system learns how each person moves and automatically changes the amount and timing of assistance to make walking feel easier and more efficient.
By using information from the person wearing the device, the exoskeleton can quickly find the level of support that works best for them.
The long-term goal is to create personalized walking assistance that can help people with mobility limitations move more comfortably and with less effort.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This project aims to develop and test a real-time adaptive controller for a robotic ankle exoskeleton (Biomotum) that personalizes assistance to each user by minimizing metabolic cost and optimizing muscle activation patterns during walking.
Using human-in-the-loop optimization and advanced musculoskeletal modeling, the controller will dynamically adjust torque magnitude and timing to achieve optimal performance more quickly than current methods.
Study Type
Interventional
Enrollment (Estimated)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Farah Fallahtafi, PhD
- Phone Number: 4025543075
- Email: ffallahtafti@unomaha.edu
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68108
- Biomechanics Research Building, University of Nebraska at Omaha
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- able to walk independently on a treadmill for 10 minutes,
- free of neurological, cardiovascular, pulmonary, or musculoskeletal conditions that limit walking and exercising,
- no current lower extremity pain or injury,
- able to wear an exoskeleton and safety harness, can provide informed consent
Exclusion Criteria:
- history of neurological disease that affected gait or balance,
- current or recent lower extremity musculoskeletal injury or surgery,
- chronic lower extremity pain during walking,
- inability to participate in moderate-intensity exercise,
- require an assistive device for walking,
- any metabolic or systemic diseases that may be exacerbated by exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single-Arm Study of a Personalized Robotic Ankle Exoskeleton Controller
This arm employs a within-subject design with two methods of estimating metabolic cost versus the gold standard measure of metabolic cost, wherein a single participant is subjected to two distinct measurements.
This design allows for a direct comparison of the effects of each method (i.e., estimation versus gold standard) within the same individual, minimizing intersubject variability and enhancing the statistical power of the analysis.
|
This intervention uses a robotic ankle exoskeleton equipped with a real-time adaptive controller that adjusts plantarflexion torque based on each participant's walking mechanics.
Unlike standard exoskeleton controllers that use fixed or pre-programmed assistance levels, this system employs human-in-the-loop optimization to continuously update torque magnitude and timing during treadmill walking.
The controller integrates metabolic estimations, kinematic data, and musculoskeletal modeling to identify individualized assistance patterns that reduce walking effort and improve muscle activation efficiency.
Participants complete multiple walking trials while the controller automatically modifies assistance to determine the optimal personalized settings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful Real-Time Operation of the Robotic Ankle Exoskeleton Controller
Time Frame: through study completion, an average of 1 year
|
Device feasibility will be evaluated by the successful real-time operation of the robotic ankle exoskeleton and adaptive controller during treadmill walking.
Feasibility is defined as the controller's ability to continuously generate, update, and apply assistive torque in real time based on incoming biomechanical and physiological data without system failure, interruption, or safety-related termination.
Successful operation will be confirmed by continuous controller function and synchronized data acquisition across walking trials.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Net Metabolic Rate During Exoskeleton-Assisted Walking Measured by Indirect Calorimetry
Time Frame: through study completion, an average of 1 year
|
Net oxygen consumption (VO₂) and carbon dioxide production (VCO₂) will be measured during treadmill walking using indirect calorimetry (Cosmed K5, Cosmed USA Inc., Chicago, IL).
Metabolic rate will be calculated using standard equations during steady-state walking conditions.
Measurements will be collected at regular intervals to characterize metabolic demand under different exoskeleton assistance configurations.
|
through study completion, an average of 1 year
|
|
Estimated Metabolic Rate Derived From Joint-Space Musculoskeletal Modeling
Time Frame: through study completion, an average of 1 year
|
Estimated metabolic rate will be derived from joint-space musculoskeletal models using kinematic and kinetic data collected during treadmill walking.
Model-based estimates will be computed on a stride-by-stride basis to provide an indirect estimate of metabolic demand that can be compared with direct measurements from indirect calorimetry.
|
through study completion, an average of 1 year
|
|
Estimated Lower-Limb Muscle Activation Derived From Joint-Space Musculoskeletal Modeling
Time Frame: through study completion, an average of 1 year
|
Lower-limb muscle activation patterns will be estimated using joint-space musculoskeletal models based on motion capture and ground reaction force data collected during treadmill walking.
Estimated muscle activation values will be computed on a stride-by-stride basis to characterize neuromuscular engagement during exoskeleton-assisted gait.
|
through study completion, an average of 1 year
|
|
Lower-Limb Muscle Activation Measured by Surface Electromyography During Walking
Time Frame: through study completion, an average of 1 year
|
Muscle activation of lower-limb muscles (e.g., tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, soleus) will be measured during treadmill walking using surface electromyography (Delsys).
EMG signals will be collected continuously and processed to quantify muscle activation patterns during exoskeleton-assisted gait.
|
through study completion, an average of 1 year
|
|
During treadmill walking trials conducted at a single study visit
Time Frame: through study completion, an average of 1 year
|
Controller parameter convergence will be assessed during human-in-the-loop optimization trials by evaluating changes in controller gain and timing parameters across successive walking bouts.
Convergence is defined as stabilization of controller parameters within a predefined range during the optimization process.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Farah Fallahtafti, PhD, Department of Biomechanics, University of Nebraska at Omaha
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
December 5, 2025
First Submitted That Met QC Criteria
January 30, 2026
First Posted (Actual)
February 6, 2026
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
June 1, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0587-25-FB
- 55136 (Other Grant/Funding Number: Nebraska Research Initiative)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will not be shared because direct measurements are only taken for baseline measurements that the modeling software will be using.
The scripts and code used will be shared through opensource, but that does not include subject data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Young Adults
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
Essilor InternationalNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingYoung Healthy AdultsHong Kong
-
Escola Superior de Tecnologia da Saúde do PortoNot yet recruitingHealthy Young AdultsPortugal
-
European University Miguel de CervantesCompletedHealthy Young AdultsSpain
-
Poznan University of Physical EducationCompletedHealthy Young AdultsPoland
-
Riphah International UniversityCompletedHealthy Young AdultsPakistan
-
Georgia Institute of TechnologyNational Institute of Neurological Disorders and Stroke (NINDS)CompletedHealthy Young AdultsUnited States
-
Touro University NevadaCompleted
-
Charite University, Berlin, GermanyCompleted
Clinical Trials on Adaptive Torque Control System for Ankle Exoskeleton
-
Georgia Institute of TechnologyEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruiting
-
Federal State Budgetary Scientific Institution...CompletedPrevention of Diseases of the Musculoskeletal SystemRussian Federation
-
Merve Damla KorkmazCompletedCerebral Palsy | Neuromuscular Scoliosis
-
Istituto Nazionale Assicurazione contro gli Infortuni...Scuola Superiore Sant'Anna di Pisa; Università Campus Bio-Medico di Roma (UCBM)RecruitingUpper Limb DeficitsItaly
-
Centre for Interdisciplinary Research in Rehabilitation...Université de Montréal; Université du Québec a MontréalTerminatedSpinal Cord InjuriesCanada
-
National Taiwan University HospitalRecruiting
-
University Health Network, TorontoCompleted
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingPatients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy
-
Federal University of UberlandiaUnknown
-
Muhammet Ayhan ORALCompletedDorsiflexion Deformity of FootTurkey